Gavin Dunn

Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms

Posted on April 12, 2021

Diane Elizabeth Bender, Maximilian O Schaettler, Kathleen CF Sheehan, Tanner M Johanns, Gavin P Dunn. (2021) Biomarker Insights, 16, . Read More

Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank

Posted on April 12, 2021

Pavlina Chuntova, […], Gavin P Dunn, […], Michael Platten, Hideho Okada. (2021) Neuro-oncology, 23 (3), pp. 356-375. Read More

Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy

Posted on October 29, 2020

Gavin P Dunn, Timothy F Cloughesy, Marcela V Maus, Robert M Prins, David A Reardon, Adam M Sonabend. Neuro-oncology, Volume 22, Issue 10, 14 October 2020, Pages 1425-1438 Read More

Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine

Posted on October 22, 2020

Connor J Liu, Maximilian Schaettler, Dylan T Blaha, Jay A Bowman-Kirigin, Dale K Kobayashi, Alexandra J Livingstone, Diane Bender, Christopher A Miller, David M Kranz, Tanner M Johanns, Gavin P Dunn. Neuro-oncology, Volume 22, Issue 9, 29 September 2020, Pages 1276-1288 Read More